
Geno.Me lands $400,000 in seed funding from Gateway Capital
A biotech startup called Geno.Me has landed $400,000 in seed funding from Gateway Capital, an early-stage investment firm based in Milwaukee. The company’s platform connects electronic health record data with genomic information from services like 23andMe, MyChart and Anscestry.com in